Strategic expansion Position IVIVA Medical as a partner for large biomedical suppliers and payers seeking plug-and-play regenerative medicine capabilities. Highlight opportunities to collaborate on scaling biomimetic platforms and 3D printed bioartificial kidney components for clinical trials and eventual commercialization.

Innovation partnerships Leverage their award-winning Phase 2 KidneyX prize status to approach government-funded programs and accelerator networks as a proof point for credibility. Propose joint grant applications, research collaborations, and contract research for organ-on-a-chip and bioprinting workflows.

Clinical development Target specialty biotech funds and academic medical centers exploring organ failure solutions. Offer pilots or milestone-based engagements around their implantable bioartificial kidney concept, combined with regulatory strategy and manufacturing scalability support.

Technology stack fit Demonstrate how IVIVA’s use of 3D printing, tissue engineering, and stem cell biology aligns with suppliers of bioprinting hardware, materials, and biocompatible scaffolds. Propose collaboration on equipment validation, training, and integrated software workflows.

Talent and capacity With a lean team, present managed collaboration models, co-development agreements, and concierge program management. Emphasize rapid decision cycles, flexible IP arrangements, and access to a network of industry mentors and potential customers.